Skip to content

Read Full Article Here: https://www.bnnbloomberg.ca/cannabis-canada-organigram-shares-slide-after-disappointing-q2-results-1.1421520

Organigram Q2 revenue, adj.

BMO Capital Markets analyst Tamy Chen said it was the third straight quarter than Organigram reported a decline in recreational cannabis revenue.

Clever Leaves books US$13M in Series E financingU.S. medical cannabis operator Clever Leaves International announced Tuesday it raised US$14 million in its latest financing round.

DAILY BUZZ13%– The share of Organigram revenue generated by its “Cannabis 2.0” products in the first two months of availability in the Canadian market.

Cannabis Canada is BNN Bloomberg’s in-depth series exploring the stunning formation of the entirely new — and controversial — Canadian recreational marijuana industry.

No comment yet, add your voice below!


Add a Comment

Your email address will not be published. Required fields are marked *

Related Articles